Background: Highly active antiretroviral therapies (HAART) increase the CD4+ cell count, but complete normalization of this parameter has not been obtained in some patients. As oxidative stress plays an important role during human immunodeficiency virus type 1 (HIV-1)-associated dementia and lymphocyte apoptosis, we asked whether the nitric oxide (NO) pathway plays a role in the in vitro survival of peripheral blood mononuclear cells (PBMC) from HIV-1 + patients and how it correlates with peripheral CD4+ cell levels. Materials and Methods: PBMC were isolated from patients with AIDS and assayed for apoptosis and proliferation in the presence of various chemicals, including agonists or antagonists of the NO path-
Introduction
HIV-1 infection leads to a progressive depletion of CD4+ T lymphocytes. Several abnormal acquired characteristics of these cells and their microenvironment have been described to explain their anergy and accelerated death (1, 2) . Oxidative stress plays a critical role during lymphocyte apoptosis in patients with AIDS (1) (2) (3) (4) . Among oxidants, the role of nitric oxide (NO) in this phenomenon remains to be deter-mined, although many authors have suggested a role for NO in various neurologic manifestations during AIDS (5) (6) (7) (8) . NO generation is mediated through the induction of macrophage inducible nitric oxide synthase (iNOS) by various inflammatory mediators and viral particles (reviewed in ref. 9) . Cocultures of astrocytes with HIV-1 -infected macrophages, but not uninfected cells, induced NO release (10) . NO expression was also induced in glial cells by HIV-1 gp4l (11) .
Highly activated antiretroviral therapies (HAART), a combination of inhibitors of HIV-1 reverse transcriptase and protease, increases the CD4+ cell count, but complete normalization has not been obtained in some of patients (12) . In the current study, we first showed that peripheral blood mononuclear cells (PBMC) from patients with peripheral low CD4+ cell counts still present an accelerated apoptosis compared to cells derived from other HAART-treated patients or uninfected donors. As these cells are more sensitive to the proapoptotic effect of oxidative burst than cells from uninfected individuals (3), we asked if they are also more sensitive to NO. We then investigated the role of NO (Table 1) . Following cell centrifugation, plasma was separated for the quantification of viral load and levels of tumor necrosis factor-a (TNF-a) and nitrites. PBMC were isolated using centrifugation on Ficoll-Hypaque gradient. Control PBMC and plasma were obtained from peripheral blood from HIV-healthy volunteers (33-52 years of age).
In Vitro Cultures PBMC were incubated in Dulbecco's modified Eagle medium (DMEM) culture medium supplemented with 10% human pooled antibody sera (Jacques Boy, Paris, France), penicillin/streptomycin, sodium pyruvate, HEPES, and L-glutamine (Gibco-BRL, Cergy Pontoise, France). Cells were also incubated in the presence of L- 10 healthy seronegative individuals were also incubated under the same culture conditions. Data in Figure 1 indicate that, in medium alone, the percentage of in vitro cell death is greater in cells from patients with AIDS than in controls (p < 0.02). Exogenous NO induced significantly higher apoptosis in AIDS cells than in cells from seronegative individuals (p < 0.009). However, variable sensitivity to NO was observed within AIDS patients. As shown in Table 2 , PBMC from patients with low (<300/mm3) peripheral blood CD4+ cell counts bPatients undergoing apoptosis analysis are numbered first with P, and those analyzed only for serum factors are numbered W.
Females are designated with an asterisk.
(10/17) had a higher in vitro sensitivity to the proapoptotic effect of NO than those with >300 CD4+ cells/Mm3 (7/17) . In contrast, sensitivity to NO was not correlated with viral load in the same patients (Table 1) . NO high levels of iHV-1 RNA copies in his plasma ( Table 1 ). The same experimental approach in three patients with low CD4+ cell numbers using iNOS-specific inhibitor L-NLL showed an inhibition of apoptosis similar to that observed with L-NMMA (-20%, -24%, and -38% apoptosis compared to controls). In addition, L-NMMA and L-NIL treatment clearly decreased the levels of nitrites detected in cell supematants following these cultures (from 8 ± 4 ,uM to 2 ± 2 ,uM). These data suggest a role for iNOS-mediated endogenous NO generation during the apoptosis of PBMC in AIDS patients having low peripheral CD4+ cell numbers.
Effects of NO and L-arginine Analog on Proliferation of PBMC from Patients with AIDS
During HIV-1 infection and AIDS, an impairment of lymphocyte functions occurs, such as unresponsiveness to recall antigens or to stimulation through the CD3/TCR complex, and decreased IL-2 secretion (1,2). We asked whether NO and L-NMMA could affect the growth response of PBMC following T cell activation. PBMC from 14 patients with AIDS were incubated with plate-bound anti-CD3 and IL-2 in the presence of SNAP (100 AM) and/or L-NMMA (500 ,uM), and the number of viable nonapoptotic cells was counted 4 days later. Data in Figure 3 show that the addition of SNAP dramatically decreased cell numbers in most (9/14) PBMC cells (p < 0.005). Addition of L-NMMA significantly increased (p < 0.03) cell responses in most patients with AIDS, regardless of their peripheral CD4+ cell counts. Figure 4 , addition of SOD significantly decreased NO-induced apoptosis, which suggests a role for superoxides in this phenomenon. NO is also known to induce cell death via activation of PARP, NAD+ depletion, and consequent ATP deficiency (17) . This pathway may play a role in NO-mediated neurotoxicity in patients with AIDS (8) . Reversion of NAD+ deficiency through the addition of exogenous nicotinamide (5 mM) or inhibition of PARP activation by 3 aminobenzamide (2 mM) significantly reversed cell apoptosis mediated by NO (Fig. 4) .
Rescue from apoptosis was observed in patient cells treated with nicotinamide alone. No inhibition was detected following cell treatment with SNAP or the inactive analogs 3-aminobenzoic acid (2 mM) or nicotinic acid (5 mM) (23 ± 8% and 27 ± 10%, respectively, compared to 25 ± 9% with SNAP alone). Together, these experiments suggest the involvement of PARP and NAD+ depletion during NO-induced apoptosis. (6) (7) (8) 11, 18, 19) . This expression may be due to macrophage activation by HIV-1 gp4l (11) or proinflammatory factors (19) (20) (21) .
The current study shows the effect of NO on peripheral leukocytes but, as previously reported (22) , it fails to establish any correlation between peripheral levels of nitrites or TNF-a and other patient parameters (Table 1) . We hypothesize that in vivo expression of NO or TNF-a is likely restricted to specific peripheral tissues rather than having systemic expression. Analysis of iNOS expression in lymph nodes and during disease progression may answer this question.
Higher sensitivity of PBMC from AIDS patients to NO correlates with their decreased levels of reduced glutathione and enhanced oxidized glutathione (4, 23) . Oxygen derivatives, including NO, may also increase HIV-1 replication through the activation of the NFKB transcription factor (24) or induction of TNF-a generation (21, 25) . Other authors have shown that antioxidants enhance CD4+ lymphocyte survival when administered to HIV-1-infected individuals, and inhibit TNF-a-and phorbol myristate acetateinduced cell death in HIV-1-infected cell lines (3, 23) . This effect was proposed to be mediated through glutathione (GSH) replenishment by N-acetylcysteine treatment. GSH is reported to reverse the proapoptotic effects of NO (3). However, further analysis of NO sensitivity of purified CD4+ and other leukocyte subpopulations are needed to clarify NO targets.
The mechanism of NO-mediated apoptosis was also investigated. Our preliminary data indicate that NO-induced apoptosis of AIDS patient cells is not mediated through cGMP generation but was significantly reversed following simultaneous addition of SOD, which may suggest the involvement of peroxynitrites in cell death. Inhibition of NO-induced apoptosis by 3-aminobenzamide and nicotinamide point out a role for PARP activation, NAD+ depletion, and consequent energy loss during NO-induced apoptosis of PBMC in patients with AIDS. Other authors have reported the involvement of this pathway during NO-mediated neurologic diseases (8, 11) as well as the ability of NAD to prevent mitochondria alteration and apoptosis in PBMC from patients with AIDS (26) . Altogether, these experiments point out the beneficial effect of iNOS inhibition as an adjuvant therapeutic approach to HAART in order to accelerate CD4+ cell increase and functional recovery.
